The advanced research center builds on the
St. Jude legacy of innovations for understanding and treating childhood cancer and other life-threatening diseases.
St. Jude recognized for having exceptional workplace culture based upon employee surveys and an in-depth questionnaire.
Researchers used a new method to model the cancer genome in 3-D and show how the c-MYC oncogene drives high-risk neuroblastoma in some patients.
Mutz will play a key role in the
St. Jude Strategic Plan and future hospital expansion.
Quality improvement effort shows the way to enhance vaccination among health care providers and protect patients.
St. Jude researchers pinpoint the cell type that turns malignant in rhabdomyosarcoma, which could open the path for better treatments.
Read about the TP53 gene variations that leave young people more likely to develop acute lymphoblastic leukemia and to die as a result.